- Home
- NERV vs ETS Comparison
NERV vs ETS Comparison
Compare NERV & ETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- ETS
- Stock Information
- Founded
- NERV 2007
- ETS 2020
- Country
- NERV United States
- ETS United States
- Employees
- NERV N/A
- ETS N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- ETS Trucking Freight/Courier Services
- Sector
- NERV Health Care
- ETS Industrials
- Exchange
- NERV Nasdaq
- ETS Nasdaq
- Market Cap
- NERV 14.6M
- ETS 14.7M
- IPO Year
- NERV 2014
- ETS 2025
- Fundamental
- Price
- NERV $2.83
- ETS $0.83
- Analyst Decision
- NERV Hold
- ETS
- Analyst Count
- NERV 1
- ETS 0
- Target Price
- NERV $5.00
- ETS N/A
- AVG Volume (30 Days)
- NERV 639.5K
- ETS 412.9K
- Earning Date
- NERV 11-04-2025
- ETS 01-01-0001
- Dividend Yield
- NERV N/A
- ETS N/A
- EPS Growth
- NERV N/A
- ETS N/A
- EPS
- NERV 1.48
- ETS N/A
- Revenue
- NERV N/A
- ETS $2,542,395.00
- Revenue This Year
- NERV N/A
- ETS N/A
- Revenue Next Year
- NERV N/A
- ETS N/A
- P/E Ratio
- NERV $1.47
- ETS N/A
- Revenue Growth
- NERV N/A
- ETS 0.74
- 52 Week Low
- NERV $1.15
- ETS $0.83
- 52 Week High
- NERV $3.29
- ETS $4.23
- Technical
- Relative Strength Index (RSI)
- NERV 70.41
- ETS N/A
- Support Level
- NERV $2.06
- ETS N/A
- Resistance Level
- NERV $2.15
- ETS N/A
- Average True Range (ATR)
- NERV 0.11
- ETS 0.00
- MACD
- NERV 0.02
- ETS 0.00
- Stochastic Oscillator
- NERV 70.72
- ETS 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About ETS Elite Express Holding Inc. Class A Common Stock
Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients' doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable, and innovative delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.